185 related articles for article (PubMed ID: 27220462)
1. Effects of TMEM9 gene on cell progression in hepatocellular carcinoma by RNA interference.
Zhang Y; Ran Y; Xiong Y; Zhong ZB; Wang ZH; Fan XL; Ye QF
Oncol Rep; 2016 Jul; 36(1):299-305. PubMed ID: 27220462
[TBL] [Abstract][Full Text] [Related]
2. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721.
Liu RT; Cao JL; Yan CQ; Wang Y; An CJ; Lv HT
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143959
[TBL] [Abstract][Full Text] [Related]
3. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
6. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
[TBL] [Abstract][Full Text] [Related]
7. Expression and inhibitory role of TIMP-3 in hepatocellular carcinoma.
Shen B; Jiang Y; Chen YR; Zheng HC; Zeng W; Li YY; Yin A; Nie Y
Oncol Rep; 2016 Jul; 36(1):494-502. PubMed ID: 27222429
[TBL] [Abstract][Full Text] [Related]
8. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.
He XQ; Zhang YF; Yu JJ; Gan YY; Han NN; Zhang MX; Ge W; Deng JJ; Zheng YF; Xu XM
Tumour Biol; 2017 Mar; 39(3):1010428317695971. PubMed ID: 28347229
[TBL] [Abstract][Full Text] [Related]
9. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
Liu S; Zhang W; Liu K; Ji B; Wang G
Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
[TBL] [Abstract][Full Text] [Related]
10. H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro.
Luo M; Xiong Y; Lin Y; Liang R; Li Y; Ge L
Med Sci Monit; 2021 May; 27():e930215. PubMed ID: 33990536
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.
Wang G; Wei Z; Jia H; Zhao W; Yang G; Zhao H
Oncol Rep; 2015 Sep; 34(3):1121-8. PubMed ID: 26151573
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of ANXA7 decreases metastatic potential of human hepatocellular carcinoma cells in vitro.
Ibrahim MM; Sun MZ; Huang Y; Jun M; Jin Y; Yue D; Jiasheng W; Zhang J; Qazi AS; Sagoe K; Tang J
Biomed Pharmacother; 2013 May; 67(4):285-91. PubMed ID: 23582794
[TBL] [Abstract][Full Text] [Related]
13. [Overexpression of protein phosphatase 2 regulatory subunit B''α gene effect on proliferation and invasion of hepatoma cells].
Chen HJ; Wang PX; Huang LL; Zhang HY; Chen XG; Zhang Q
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):872-878. PubMed ID: 31941242
[No Abstract] [Full Text] [Related]
14. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
15. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism.
Li W; Shen S; Wu S; Chen Z; Hu C; Yan R
Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877
[TBL] [Abstract][Full Text] [Related]
16. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H.
Lin Q; Peng S; Yang Y
Int J Oncol; 2018 Jul; 53(1):266-274. PubMed ID: 29749468
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-377 contributes to IRX3 deregulation in hepatocellular carcinoma.
Wang P; Zhuang C; Huang D; Xu K
Oncol Rep; 2016 Jul; 36(1):247-52. PubMed ID: 27222047
[TBL] [Abstract][Full Text] [Related]
19. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression.
Hu B; Yan X; Liu F; Zhu C; Zhou H; Chen Y; Liu J; Gu X; Ni R; Zhang T
Pathol Oncol Res; 2016 Jul; 22(3):555-65. PubMed ID: 26715439
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1.
Hou Z; Xu X; Zhou L; Fu X; Tao S; Zhou J; Tan D; Liu S
Tumour Biol; 2017 Jul; 39(7):1010428317718135. PubMed ID: 28720061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
